Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/2/2025

Doxycycline Side Effects and Management

Common Side Effects

  • Nausea, vomiting, and diarrhea are the most frequent adverse effects, occurring in approximately 15.7% of patients compared to 5.9% with placebo 1
  • Dysphagia and abdominal discomfort occur commonly, particularly with standard formulations 2, 3
  • Photosensitivity and rash are the most common skin reactions 2, 3, 4, 5

Serious Side Effects Requiring Immediate Attention

  • Esophagitis and esophageal ulcerations can occur in patients on long-term therapy 2, 4, 5
  • Pseudomembranous colitis (C. difficile infection) can develop 2, 4, 5
  • Hepatotoxicity including hepatitis, jaundice, and hepatic failure (rare but potentially fatal) 2, 4, 5
  • Stevens-Johnson syndrome and toxic epidermal necrolysis are life-threatening conditions 2, 3, 4, 5
  • Benign intracranial hypertension (pseudotumor cerebri) presents with headache and visual changes 2, 3, 4, 5
  • Anaphylaxis and anaphylactoid reactions (including shock and fatalities) can occur 2, 4, 5

Critical Prevention Strategies

  • Take doxycycline with a full glass of water (at least 200ml) while sitting or standing to prevent esophageal ulceration 2, 3, 4, 5
  • Separate from antacids containing aluminum, calcium, or magnesium by 2-3 hours 2, 3, 4, 5
  • Avoid concurrent iron-containing preparations 3
  • Separate from caffeine and vitamin C by 1-2 hours as they reduce bioavailability 6
  • Avoid extensive sunlight or UV irradiation throughout treatment 1, 2, 4, 5

Monitoring Requirements

  • Intermittent monitoring of CBC, renal function (U&Es), and liver function tests (LFTs) throughout treatment 2, 4, 5

Absolute Contraindications

  • Hypersensitivity to doxycycline or other tetracyclines 2, 3, 4, 5
  • Children under 12 years of age due to permanent tooth discoloration and enamel hypoplasia 2, 4, 5
  • Pregnancy (Category D) and breastfeeding 3

Special Cautions

  • Hepatic impairment or concurrent hepatotoxic drugs 2, 4, 5
  • Myasthenia gravis (risk of neuromuscular blockade) 2, 4, 5
  • Systemic lupus erythematosus (risk of exacerbation) 2, 4, 5
  • Porphyria 2, 4, 5